Table 3.
Definition | ||||
---|---|---|---|---|
VA1 | VA2 | CDC1 | CDC2 | |
No. of CRE isolatesa | 369 (1.7%) | 308 (1.4%) | 316 (1.5%) | 404 (1.9%) |
No. of unique patientsb | 149 (2.1%) | 127 (1.8%) | 116 (1.7%) | 174 (2.5%) |
Organism isolated | ||||
E. coli | 17 (11.4%) | 16 (12.6%) | 8 (6.9%) | 23 (13.2%) |
Klebsiella spp. | 93 (62.4%) | 88 (69.3%) | 85 (73.3%) | 105 (60.3%) |
Enterobacter spp. | 39 (26.2%) | 23 (18.1%) | 23 (19.8%) | 46 (26.4%) |
Culture source | ||||
Urine | 99 (66.4%) | 87 (68.5%) | 81 (69.8%) | 119 (68.4%) |
Blood | 11 (7.4%) | 8 (6.3%) | 9 (7.8%) | 12 (6.9%) |
Sputum | 20 (13.4%) | 14 (11.0%) | 12 (10.3%) | 21 (12.1%) |
Otherc | 19 (12.8%) | 18 (14.2%) | 14 (12.1%) | 22 (12.6%) |
No. of CRE isolates by facility complexity and location | ||||
1a-1c (High) | 363 (98.4%) | 297 (96.4%) | 309 (97.8%) | 392 (97.0%) |
2-3 (Low) | 6 (1.6%) | 11 (3.6%) | 7 (2.2%) | 12 (3.0%) |
Urban | 368 (99.7%) | 305 (99.0%) | 314 (99.4%) | 401 (99.3%) |
Rural | 1 (0.3%) | 3 (1.0%) | 2 (0.6%) | 3 (0.7%) |
CRE, carbapenem-resistant Enterobacteriaceae
Out of 21,514 total E. coli, Klebsiella spp., and Enterobacter spp. isolates
Out of 6,974 unique patients with at least one E. coli, Klebsiella spp., and/or Enterobacter spp. isolate
Wound, tissue, and fluid